Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q2365016> ?p ?o }
Showing triples 1 to 55 of
55
with 100 triples per page.
- Q2365016 subject Q52376.
- Q2365016 subject Q7145095.
- Q2365016 subject Q7334142.
- Q2365016 subject Q8462603.
- Q2365016 subject Q8965786.
- Q2365016 abstract "Gatifloxacin sold under the brand names Gatiflo, Tequin and Zymar, is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Bristol-Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin for the treatment of respiratory tract infections, having licensed the medication from Kyorin Pharmaceutical Company of Japan. Allergan produces it in eye-drop formulation under the names Zymar and Zymaxid. In many countries, gatifloxacin is also available as tablets and in various aqueous solutions for intravenous therapy.".
- Q2365016 atcPrefix "J01".
- Q2365016 atcSuffix "MA16".
- Q2365016 casNumber "112811-59-3".
- Q2365016 chEBI "5280".
- Q2365016 drugbank "DB01044".
- Q2365016 fdaUniiCode "81485Y3A9A".
- Q2365016 iupacName "1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid".
- Q2365016 pubchem "5379".
- Q2365016 thumbnail Gatifloxacin.svg?width=300.
- Q2365016 wikiPageWikiLink Q10876.
- Q2365016 wikiPageWikiLink Q1196645.
- Q2365016 wikiPageWikiLink Q12187.
- Q2365016 wikiPageWikiLink Q12206.
- Q2365016 wikiPageWikiLink Q204711.
- Q2365016 wikiPageWikiLink Q206077.
- Q2365016 wikiPageWikiLink Q266423.
- Q2365016 wikiPageWikiLink Q420548.
- Q2365016 wikiPageWikiLink Q426549.
- Q2365016 wikiPageWikiLink Q431289.
- Q2365016 wikiPageWikiLink Q4423793.
- Q2365016 wikiPageWikiLink Q45959.
- Q2365016 wikiPageWikiLink Q52376.
- Q2365016 wikiPageWikiLink Q582728.
- Q2365016 wikiPageWikiLink Q640448.
- Q2365016 wikiPageWikiLink Q7145095.
- Q2365016 wikiPageWikiLink Q7334142.
- Q2365016 wikiPageWikiLink Q7824976.
- Q2365016 wikiPageWikiLink Q8047.
- Q2365016 wikiPageWikiLink Q8462603.
- Q2365016 wikiPageWikiLink Q871232.
- Q2365016 wikiPageWikiLink Q879952.
- Q2365016 wikiPageWikiLink Q8965786.
- Q2365016 wikiPageWikiLink Q906356.
- Q2365016 atcPrefix "J01".
- Q2365016 atcSuffix "MA16".
- Q2365016 casNumber "112811".
- Q2365016 chebi "5280".
- Q2365016 drugbank "DB01044".
- Q2365016 iupacName "1".
- Q2365016 pubchem "5379".
- Q2365016 unii "81485".
- Q2365016 type ChemicalSubstance.
- Q2365016 type Drug.
- Q2365016 type ChemicalObject.
- Q2365016 type Thing.
- Q2365016 type Q8386.
- Q2365016 comment "Gatifloxacin sold under the brand names Gatiflo, Tequin and Zymar, is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Bristol-Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin for the treatment of respiratory tract infections, having licensed the medication from Kyorin Pharmaceutical Company of Japan.".
- Q2365016 label "Gatifloxacin".
- Q2365016 depiction Gatifloxacin.svg.